NanoPhilic Biotech Company Profile, Contacts & Intelligence

NanoPhilic Biotech Overview

World's First Alzheimer's Disease Blood Test. Early detection indicator, small drop of blood, accurate, inexpensive, and coming to a market near you in the U.S. and Internationally. Reach out for inquiries on how to add this critical test to your medical practice. We have the world's first laboratory diagnostic test for Alzheimer's Disease analyzed and validated at a certified clinical laboratory (CLIA). Developed over the past 18 years. Substantial clinical validation to support it's use for a community desperate for answers and tools to help mitigate and treat this debilitating disease. OAB blood test for early detection of Alzheimers. NanoPhilic is a white glove service provider for companies looking to enter the biotech/life sciences market or expand their portfolio. Founded by industry leaders from the world's premier academic research institutions and venture capital firms. We identify, facilitate and manage efficient pathways to market from concept through approval, market adoption and distribution. We manage global assets and help expand portfolios through our sister companies and vast network for high order impact and maximum efficiency supported by leading edge technology and key opinion leaders.

Headquarters

Park City, Utah, United States

Website

www.nanophilic.com

Industry

Biotechnology Research

Founded

2020

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Compare Similar Companies to NanoPhilic Biotech

Explore companies in related markets and compare their industry and employee estimates.